Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders

Biological Chemistry

Volumn 384, Issue 2, 2003, Pages 281-287

  Werle, Bernd ^a,b   Sauckel, Kirsten ^a   Nathanson, Carl Michael ^c   Bjarnadottir, Maria ^c   Spiess, Eberhard ^d   Ebert, Werner ^a   Abrahamson, Magnus ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cysteine peptidases; Lung inflammation; Mesothelioma; Peptidase inhibitors; Pleural effusion

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN; CYSTATIN C; CYSTATIN E; CYSTATIN F; CYSTATIN M; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; EMPYEMA; FEMALE; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE COUNT; LUNG DISEASE; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; NEUTROPHIL; PLEURA DISEASE; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIORITY JOURNAL; TUBERCULOUS PLEURISY; TUMOR CELL;

BACTERIA (MICROORGANISMS);

EID: 0037300636     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.031     Document Type: Article

References (32)

1. Abrahamson, M., Barrett, A.J., Salvesen, G., and Grubb, A. (1986). Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 261, 11282-11289.
2. Abrahamson, M., Dalbøge, H., Olafsson, I., Carlsen, S., and Grubb, A. (1988). Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett. 236, 14-18.
3. Abrahamson, M., Mason, R.W., Hansson, H., Buttle, D., Grubb, A., and Ohlsson, K. (1991). Human cystatin C. Role of the N-terminal segment in the inhibition of human cysteine proteinases and its inactivation by leucocyte elastase. Biochem. J. 273, 621-626.
4. Abrahamson, M. (1994). Cystatins. Methods Enzymol. 244, 685-700.
5. Alvarez-Fernandez, M., Barrett, A.J., Gerhartz, B., Dando, P.M., Ni, J., and Abrahamson, M. (1999). Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274, 19195-19203.
6. Bieth, J.G. (1984). In vivo significance of kinetic constants of protein proteinase inhibitors. Biochem. Med. 32, 387-397.
7. Burnett, D., Abrahamson, M., Devalia, J.L., Sapsford, R.J., Davies, R.J., and Buttle, D.J. (1995). Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin A activity by neutrophil elastase. Arch. Biochim. Biophys. 317, 305-310.
8. Buttle, D.J., Burnett, D., and Abrahamson, M. (1990). Levels of neutrophil elastase and Cathepsin B activities, and cystatins in human sputum, relationship to inflammation. Scand. J. Clin. Lab. Invest. 50, 509-516.
9. 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem. J. 276, 325-331.
10. Calkins, C.C., and Sloane, B.F. (1995). Mammalian cysteine protease inhibitors: biochemical properties and possible role in tumour progression. Biol. Chem. Hoppe-Seyler 376, 76-80.
11. Dayhoff, M.O., Barker, W.C., and Hunt, L.T. (1979). In: Atlas of Protein Sequence and Structure, Vol. 5, M. O. Dayhoff, ed. (Washington, USA: National Biomedical Research Foundation), pp. 9-20.
12. Ebert, E., Werle, B., Jülke, B., Kopitar-Jerala, N., Kos, J., Lah, T.T., Abrahamson, M., Spiess, and E., Ebert, W. (1997). Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumour tissue. Ad. Exp. Med. Biol. 421, 259-265.
13. Freije, J.P., Balbín, M., Abrahamson, M., Velasco, G., Dalbøge, H., Grubb, A., and López-Otín, C. (1993). Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva. J. Biol. Chem. 268, 15737-15744.
14. Ghiso, J., Jensson, O., and Frangione, B. (1986). Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Ice-landic type is a variant of gamma-trace basic protein (cystatin C). Proc. Natl. Acad. Sci. USA 83, 2974-2978.
15. 2-microglobulin as a measure of glomerular filtration rate. Acta Med. Scand. 218, 499-503.
16. Guesdon, J. L., Ternynck, T., and Avrameas, S. (1979). The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27, 1131-1139.
17. Håkansson, K., Huh, C., Grubb, A., Karlsson, S., and Abrahamson, M. (1996). Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. Comp. Biochem. Physiol. 114B, 303-311.
18. Halfton, Sh., Ford, J., Foster, J., Dowling, L., Lucian, L., Sterling, M., Xu, Y., Weiss, M., Ikeda, M., Liggett, D., Helms, A., Caux, Ch., Lebecque, S., Hannum, Ch., Menon, S., McClanahan, T., Gorman, D., and Zurawski, G. (1998). Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J. Biol. Chem. 273, 16400-16408.
19. Henskens, Y.M.C, Veerman, E.C.I, and Amerongen, A.V.N. (1996). Cystatins in health and diseases. Biol. Chem. Hoppe-Seyler 377, 71-86.
20. Hopsu-Havu, V., Järvinen, M., and Rinne, A. (1983). Separation of cysteine proteinase inhibitors from psoriatic scale. Br. J. Dermatol. 109, 77-85.
21. Ichimaru, E, Imura, K, Hara, Y, Kato, Y, and Kato, I. (1992). Cystatin activity in gingival crevicular fluid from periodontal disease patients measured by a new analysis method. J. Periodont. Res. 27, 119-125.
22. Knoch, H., Werle, B., Ebert, W., and Spiess, E. (1994). Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol. 55, 77-85.
23. Kos, J., Stabuc, B., Schweiger, A., Krasovec, M., Cimerman, N., Kopitar-Jerala, N., and Vrhovec, I. (1997). Cathepsins B, H, L, their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3, 1815-1822.
24. Lüthgens, K., Ebert, W., Trefz, G., Grabrijelcic, D., Turk, V., and Lah, T.T. (1993). Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar fluid of lung cancer patients. Cancer Detect. Prevent. 17, 387-397.
25. Ni, J., Abrahamson, M., Zhang, M., Alvarez- Fernandez, M., Grubb, A., Su, J., Yu, G.-L., Li, Y., Parmelee, D., Xing, L., Coleman, T.A., Lima, S., Thotakura, R., Nguyen, N., Hesselberg, M., and Gentz, R. (1997). Cystatin E/M, a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J. Biol. Chem. 272, 10853-10858.
26. r cysteine proteinase inhibitor. J. Biol. Chem. 273, 24797-24804.
27. Olafsson, I., Löfberg, M., Abrahamson, M., and Grubb, A. (1988). Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand. J. Lab. Invest. 48, 573-582.
28. Pfeifer, M., Heinrich, J., and Schmidt, M. (1990). Die proteolytische Akitivität und Inhibitionskapazität im malignen Pleuraerguß. Atemwegs- und Lungenkrankheiten 16, 409-413.
29. Pierre, P., and Mellman, I. (1998). Developmental regulation of in-variant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93, 1135-1145.
30. Rawlings, N.D., and Barrett, A.J. (1990). Evolution of proteins of the cystatin superfamily. J. Mol. Evol. 30, 60-71.
31. Randers, E., and Erlandsen, E.J. (1999). Serum cystatin C as an endogenous marker of the renal function - a review. Clin. Chem. Lab. Med. 37, 389-395.
32. Sotiropoulou, G., Anisowicz, A., and Sager, R. (1997). Identification, cloning, and characterization of cystatin M, a novel cysteine protease inhibitor, down-regulated in breast cancer. J. Biol. Chem. 272, 903-910.